Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
1.12
Oct 30 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Aftermarket Close
1.10
Aftermarket • 7:52 PM ET Dollar change-0.02 Percentage change(-1.79%)
Index
-
Market Cap
162.22M
Enterprise Value
188.90M
Income
-168.20M
Sales
232.70M
Book/sh
1.36
Cash/sh
1.27
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
686
IPO
Sep 15, 2021
P/E
-
Forward P/E
6.02
PEG
-
P/S
0.70
P/B
0.82
P/C
0.88
P/FCF
5.68
EV/EBITDA
5.35
EV/Sales
0.81
Quick Ratio
1.77
Current Ratio
1.77
Debt/Eq
1.15
LT Debt/Eq
1.08
Option/Short
Yes / Yes
EPS (ttm)
-1.61
EPS next Y
0.19
EPS next Q
0.04
EPS this Y
-18.54%
EPS next Y
-4.86%
EPS next 5Y
-8.31%
EPS past 3/5Y
-163.26% -19.83%
Sales past 3/5Y
2.75% 15.34%
EPS Y/Y TTM
39.52%
Sales Y/Y TTM
-4.99%
EPS Q/Q
27.58%
Sales Q/Q
-9.14%
Insider Own
70.56%
Insider Trans
0.00%
Inst Own
22.84%
Inst Trans
-2.43%
ROA
-26.55%
ROE
-75.04%
ROIC
-56.01%
Gross Margin
60.13%
Oper. Margin
-8.45%
Profit Margin
-72.28%
SMA20
7.00%
SMA50
14.47%
SMA200
3.92%
Trades
Shs Outstand
106.41M
Shs Float
31.43M
52W High
3.00 -62.67%
52W Low
0.61 83.52%
Volatility
5.39% 5.25%
ATR (14)
0.06
RSI (14)
63.95
Beta
1.44
Rel Volume
0.72
Avg Volume
618.08K
Volume
447,913
Perf Week
3.70%
Perf Month
19.65%
Perf Quarter
60.00%
Perf Half Y
13.57%
Perf YTD
-60.98%
Perf Year
-58.21%
Perf 3Y
-81.21%
Perf 5Y
-97.21%
Perf 10Y
-
Prev Close
1.12
Price
1.12
Change %
0.00%
Consensus
Hold
Avg. Price Target
$1.62
Implied Upside
+44.6%
Analysts14incl. previous ratings
Rating Distribution3 Buy · 8 Hold · 3 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jun 29, 2026Downgrade
BAC logoBBofA Securities
Buy → Underperform$0.70-37.5%
May 09, 2025Downgrade
BBTIG Research
Buy → Neutral
Jan 13, 2025Downgrade
BCS logoBBarclays
Equal Weight → Underweight$4+257.1%
Dec 20, 2024Initiated
SStephens
Equal-Weight$5+346.4%
Sep 17, 2024Initiated
BBTIG Research
Buy$7+525.0%
Jul 31, 2024Downgrade
JPM logoJJP Morgan
Neutral → Underweight$7 → $5+346.4%
May 08, 2024Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight$11.50 → $9+703.6%
Jan 17, 2024Downgrade
NNeedham
Buy → Hold
Jan 05, 2024Downgrade
CCanaccord Genuity
Buy → Hold
Jul 24, 2023Downgrade
RRobert W. Baird
Outperform → Neutral$13+1,060.7%
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.
Founder & Executive ChairmanMr. Jason Ronald Krantz
Chief Financial OfficerMs. Casey Heller
CEO & DirectorMr. Clay Ritchey
Chief Legal Officer & SecretaryMr. Jonathan Paris J.D.
SVP & Head of SalesMs. Marissa Peoples Odell